A study of IDH-wildtype glioblastoma patients found that monocyte recovery during chemoradiotherapy is independently prognostic for longer survival, using a dynamic blood measure rather than a single baseline snapshot. In cardiometabolic care, a large meta-analysis concluded that blood-pressure reductions from GLP-1 receptor agonists and multi-hormone receptor modulators are driven mostly by weight loss (about 76% explained by weight reduction), reinforcing the mechanistic framing clinicians use for counseling and expectations. Separately, new work suggests composite blood markers can guide inflammatory risk stratification in thyroid disorders, adding to the trend toward simpler “lab-derived” trajectories for monitoring and decision-making.